Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
| 301 | 3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY//LEVOSIMENDAN//PHARMACOLOGY & PHARMACY | 41522 |
| 1503 | 2 | NEBIVOLOL//CARVEDILOL//BETA BLOCKERS | 7786 |
| 13717 | 1 | OSTRA HOSP MED 1//RECEPTOR OCCUPANCY THEORY//DEPRESSIVE DISORDER CHEMICALLY INDUCED | 847 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | OSTRA HOSP MED 1 | address | 74417 | 0% | 100% | 2 |
| 2 | RECEPTOR OCCUPANCY THEORY | authKW | 66973 | 0% | 60% | 3 |
| 3 | DEPRESSIVE DISORDER CHEMICALLY INDUCED | authKW | 49610 | 0% | 67% | 2 |
| 4 | DRUG INDUCED DEPRESSION | authKW | 49610 | 0% | 67% | 2 |
| 5 | 2 DIMENSIONAL OUTCOME | authKW | 37208 | 0% | 100% | 1 |
| 6 | ADRENOCORTICAL DRUGS | authKW | 37208 | 0% | 100% | 1 |
| 7 | ADVERSE PULMONARY EFFECT | authKW | 37208 | 0% | 100% | 1 |
| 8 | ALPHA BETA ADRENERGIC BLOCKADE | authKW | 37208 | 0% | 100% | 1 |
| 9 | ANTIHYPERPROLACTINEMIC ACTIVITY | authKW | 37208 | 0% | 100% | 1 |
| 10 | AVD KLINISK FARMAKOL | address | 37208 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 8463 | 58% | 0% | 488 |
| 2 | Medicine, General & Internal | 1232 | 19% | 0% | 158 |
| 3 | Psychiatry | 706 | 11% | 0% | 96 |
| 4 | Medicine, Research & Experimental | 341 | 9% | 0% | 73 |
| 5 | Cardiac & Cardiovascular System | 246 | 8% | 0% | 67 |
| 6 | Toxicology | 115 | 4% | 0% | 36 |
| 7 | Psychology | 80 | 3% | 0% | 22 |
| 8 | Peripheral Vascular Diseases | 42 | 3% | 0% | 24 |
| 9 | Chemistry, Medicinal | 24 | 2% | 0% | 20 |
| 10 | Primary Health Care | 21 | 1% | 0% | 5 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | OSTRA HOSP MED 1 | 74417 | 0% | 100% | 2 |
| 2 | AVD KLINISK FARMAKOL | 37208 | 0% | 100% | 1 |
| 3 | DETP HLTH HUMAN SERV | 37208 | 0% | 100% | 1 |
| 4 | DUKE VET ADM CEREBROVASC NEUROL SECT | 37208 | 0% | 100% | 1 |
| 5 | KLINIKAI KUTATASI MENTALHIGIENES OSZTALY | 37208 | 0% | 100% | 1 |
| 6 | KUTVOLGYI KLINIKAI TOMB | 37208 | 0% | 100% | 1 |
| 7 | MED PHARM PHARM PHARMACEUT | 37208 | 0% | 100% | 1 |
| 8 | NEUROPSZICHOFARMAKOL NEUROKEMIAI KUTATOCSOPORT | 37208 | 0% | 100% | 1 |
| 9 | RIGSHOSPGLOSTRUP HOSP | 37208 | 0% | 100% | 1 |
| 10 | TOBACCO DIS RELATED PROGRAM | 37208 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 28191 | 9% | 1% | 79 |
| 2 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 20611 | 7% | 1% | 63 |
| 3 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 8944 | 4% | 1% | 34 |
| 4 | ANNALS OF CLINICAL RESEARCH | 6234 | 1% | 2% | 10 |
| 5 | JOURNAL OF CLINICAL PHARMACOLOGY | 4880 | 3% | 0% | 27 |
| 6 | DRUGS | 4713 | 3% | 0% | 27 |
| 7 | PHARMAKOPSYCHIATRIE NEURO-PSYCHOPHARMAKOLOGIE | 3626 | 0% | 5% | 2 |
| 8 | BRITISH JOURNAL OF CLINICAL PRACTICE | 3025 | 2% | 1% | 13 |
| 9 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 3008 | 2% | 0% | 18 |
| 10 | ACTA THERAPEUTICA | 2393 | 0% | 2% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |